Knowledge Center

Patent / Jan 01, 1999

Process for the preparation of crystalline and solvent-free iohexol

Authors:
  • Guy Villax
  • Carlos Alvarez
Source:
AU 696647

An industrial-scale process for the purifn. and removal of residual solvents from the X-ray contrast agent iohexol is presented which is based on the suspension of cryst. iohexol, eventually contg. residual solvents above 100 ppm, in a fluid where it has a low soly. (e.g., EtOH), followed by heating, filtration, and drying. The process allows the formation of cryst. iohexol with a residual org. solvent content of .ltoreq.100 ppm and with an increased purity level.

Also in the Knowledge Center

Related Content

¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð®

Make your drug soluble with ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® technology. ¶Ù¾±²õ±è±ð°ù²õ´Ç³¾±ð® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Inhalation devices

ËÄÉ«AV’s inhalers offer our business partners access to simple, multipurpose, easy to use, globally competitive alternatives for inhalation delivery devices.

Page
Read more

Contact Us

Page
Read more